Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02299
Species: Homo sapiens
Position : chr8:128840000-128890000
Year: 2023
Title: SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: rhabdoid tumor
PMID:  38040699
MONDO: MONDO:0002728
Tissue: kidney
Tissue Ontology ID: UBERON:0002113
Cell Source: MRT patient-derived organoids (P103)
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Chromatin interaction assay, Enhancer activity assay, TF binding assay, Functional perturbation assay; Chromatin-state profiling
High Throughput Method: Hi-C, 3C-seq, ATAC-seq, ChIP-seq, RNA-seq; single-cell RNA-seq; RNA-seq; ATAC-seq
Low Throughput Method: 3C-RT-qPCR, qRT-PCR, Western blot
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_03876 chr8:126650000-129950000 colon malignant cell NA
Expression of Target Genes for the Enhancer